-
Company Insights
Future Unicorns in Healthtech
Based on the GlobalData Machine Learning Model’s proprietary ranking of 10,000 top startups, 120 Healthtech startups have been shortlisted globally, with 50 of them predicted to become future unicorns. The 10k top startups in the Scorecard are spread over 70 countries with the US accounting for half of them, followed by China. Positive sentiments in the news, continued VC investments, increase in hiring clubbed with growing Healthtech mentions in Company Filings indicate that the Healthtech sector has high interest for...
-
Thematic Analysis
Future Unicorn Predictions – Spot Tomorrow’s Winners Today
This report compendium consists of 5 reports that are based on GlobalData’s proprietary ranking of 10,000 top startups. The list has been compiled using GlobalData’s Quant-based Startup Scorecard tool combined with proprietary Machine Learning (ML) algorithms. The tool accurately predicts promising future Unicorns (Startups predicted to be valued at US$1bn or more) by analyzing the crucial indicators of previously identified Unicorns. Use GlobalData’s intelligence to help you to spot tomorrow’s winners today.
-
Analyst Opinions
Engineering Microorganisms into Powerful Micromachines: Can Synthetic Biology Foster Bio-Revolution?
Achieving global goals such as mass-scale food production and sustainable low-cost manufacturing methods is the need of the hour. Synthetic Biology (SynBio) is a field of science that has grown over the last two decades to emerge as a mature area in biological engineering with its potential to reduce the costs of biological production methods and improve the global food supply. It also can be crucial to create patient-centric drugs and promote precision medicine for better health outcomes. SynBio is...
-
Company Insights
Future Artificial Intelligence (AI) Unicorns
This report analyzes the top 50 Artificial Intelligence startups from the “GlobalData Startup Scorecard” that has the potential to become unicorns (valuation more than US$1bn) based on the GlobalData’s Unicorn Prediction Model. The model is based on a proprietary machine learning (ML) algorithm which analyzes millions of data points related to venture capital (VC) investment activity for startups and can predict future unicorns.
-
Track & Monitor
Coronavirus Disease (COVID-19) Impact on Biopharmaceutical Venture Capital Deals
This report examines the impact of the COVID-19 pandemic on venture capital deals for biopharmaceutical companies. This analysis is critical to understanding how the outbreak of COVID-19 impacted investments and how those VC deal trends may impact current and future venture capital investments.